Track topics on Twitter Track topics that are important to you
Phone: 49 9221 82762-0
Fax: 49 9221 82762-99
Sanofi and Alnylam Pharmaceuticals amended their 2012 deal to give Alnylam global development and marketing rights to transth -More-
Regeneron and Alnylam are to research treatments for the chronic liver disease non-alcoholic steatohepatitis (NASH), under a new agreement. Alnylam specialises in treatments based around RNA interfer...
Alnylam Pharmaceuticals, Inc. and Sanofi announced a strategic restructuring of their RNAi therapeutics alliance to streamline and optimize development and commercialization of certain products for th...
The five-year deal will help support Alnylam's planned market launch of its RNAi therapeutic patisiran.
Alnylam Pharmaceuticals' marketing application for patisiran, which is being developed as a treatment for patients with hered -More-
Alnylam Pharmaceuticals and French pharma major Sanofi today announced a strategic restructuring of their…
Regeneron Pharmaceuticals and Alnylam Pharmaceuticals will collaborate to identify RNAi therapeutics…
Alnylam Pharmaceuticals' patisiran, which is being developed as a treatment for patients with hereditary ATTR amyloidosis, wa -More-
Nizatidine Capsules USP Rx only
MANICURE by OPI FINISHING BUTTER
Retavase Reteplase, recombinant
Farming was first introduced to Europe in the mid-seventh millennium bc, and was associated with migrants from Anatolia who settled in the southeast before spreading throughout Europe. Here, to unders...
In the past decade, a large influx of migrants presented in Europe. Their country of origin was mainly either Syria or Eritrea. Public health institutions in host countries in Europe are challenged to...
Are there any changes in the treatments involving ART and IUI initiated in Europe during 2013 compared with previous years?
In industrialized areas of the world, including Europe, Hepatitis E Virus (HEV) is considered an emerging pathogen. In fact, autochthonous cases caused by HEV genotype 3 (HEV-3) are increasingly repor...
This study is conducted in Europe. The aim of this study is to investigate usage of liraglutide for weight management in clinical practice.
This multicenter, prospective, single-arm, phase 3 study will assess the proportion of disease-free patients, starting from administration of the first study treatment to at least 12-month...
The investigators want to identify and show differences in standards and procedures of in-hospital rapid sequence induction by collecting data with an online survey for anaesthetist in Eur...
This is a prospective, non-interventional study (NIS) measuring health-related quality of life (HRQoL), treatment satisfaction, and other patient-reported outcomes (PROs) of ADPKD patients...
PATHWAYS is a 3-year project that directly contributes to the 2014 Work Programme by focusing on action 188.8.131.52 regarding the development of innovative approaches to promote the profession...
Alnylam ist ein biopharmazeutisches Unternehmen, das neuartige Therapeutika auf Basis der RNA-Interferenz (RNAi) entwickelt und hierbei eine führende Position inne hat. Die RNAi stellt einen Durchbru...
Alnylam Pharmaceuticals, a leader in RNAi therapeutics, is a biopharmaceutical company developing novel therapeutics based on a breakthrough in biology known as RNA interference, or RNAi; a discovery ...
Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company is leading the translation of RNAi as a new class of innovative medicines with a ...
Europe Unlimited profiles and connects the community of Europe’s best tech entrepreneurs and international capital through research, networking events and consulting. As such, we are in a position t...
We have published hundreds of Alnylam Europe AG news stories on BioPortfolio along with dozens of Alnylam Europe AG Clinical Trials and PubMed Articles about Alnylam Europe AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alnylam Europe AG Companies in our database. You can also find out about relevant Alnylam Europe AG Drugs and Medications on this site too.
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...